Is UnitedHealth (UNH) a Buy as Wall Street Analysts Look Optimistic?

UnitedHealth Group (UNH) has an average brokerage recommendation of 1.54 (Strong Buy/Buy) from 27 firms, with 66.7% Strong Buy ratings. However, the article cautions that brokerage recommendations often carry positive bias due to vested interests. The company's Zacks Rank #2 (Buy) rating is based on earnings estimate revisions, with consensus estimates increasing 0.7% over the past month to $19.85, suggesting analyst optimism about the company's earnings prospects.